Bright Minds Biosciences (DRUG) Tax Provisions (2025)

Bright Minds Biosciences' (DRUG) quarterly Tax Provisions came in at -$187376.6 in Q3 2025, down 200.68% on a QoQ basis from $186107.3 in Q2 2025.

Analysis

Bright Minds Biosciences (DRUG) Tax Provisions (2025) Analysis & Trends

Bright Minds Biosciences (DRUG) has 1 years of Tax Provisions data on file, last reported at -$187376.6 in Q3 2025.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Taxes (Qtr)
1	Vertex Pharmaceuticals	139.31 Bn	131.46 Bn	2.84 Bn	292.00 Mn
2	Regeneron Pharmaceuticals	85.65 Bn	77.66 Bn	3.93 Bn	230.90 Mn
3	Argenx Se	63.46 Bn	58.27 Bn	1.37 Bn	-59.00 Mn
4	Moderna	57.94 Bn	52.80 Bn	52.00 Mn	15.00 Mn
5	Revolution Medicines	44.05 Bn	44.05 Bn	-	-
6	BeOne Medicines	39.96 Bn	34.86 Bn	1.53 Bn	75.45 Mn
7	Alnylam Pharmaceuticals	35.16 Bn	31.85 Bn	992.69 Mn	13.31 Mn
8	Royalty Pharma	28.44 Bn	27.60 Bn	-	-
9	Insmed	27.32 Bn	26.16 Bn	358.27 Mn	1.90 Mn
10	Bright Minds Biosciences	459.66 Mn	237.12 Mn	-	-

Historic Data

Download Data

Date	Value
Sep 30, 2025	-187,376.64
Jun 30, 2025	186,107.28